DISPERSIBLE EDGE FUNCTIONALISED GRAPHENE PLATELETS

Abstract

The present disclosure provides a dispersible graphene platelet and a method of making same. The structure of the graphene platelet 10 comprises a base layer 1 of graphene on which at least one discontinuous layer 2, 3, 4 of graphene is stacked, with each layer of graphene above the base layer having a smaller surface area than the layer it is stacked upon. The edges of the base layer and the discontinuous layers stacked upon it are all at least partially functionalised 5, providing a structure with graphene-like properties owing to the base layer and relatively high dispersibility owing to the increased amount of functionalised groups on each platelet. The platelets may be used for a number of applications, for example in the production of electrodes or composite materials.

Claims

1.-32. (canceled)

33. A dispersible graphene platelet including: a base layer of graphene; at least one discontinuous graphene layer stacked on the base layer; wherein the at least one discontinuous layer has a smaller surface area than the base layer; and, wherein the edge regions of the base layer and the at least one discontinuous layer are at least partially functionalised.

34. The platelet according to claim 33, wherein the platelet is able to form a stable dispersion in water at concentrations up to 700 mg/mL.

35. The platelet according to claim 33, wherein the electrical conductivity of the platelet is approximately 900 S/cm.

36. The platelet according to claim 33, wherein the platelet is further functionalised by the addition of metal ions to at least one of the functionalised edges or the surface, and wherein the metal ions are selected from Fe, Cu, Co, and Sn.

37. A polymer-matrix composite material comprising a polymer; and graphene platelets according to claim 33.

38. The polymer-matrix composite material according to claim 37 wherein the polymer is selected from alginate, chitosan, PVA, PEG, PU, PEI, PVDF, PDMS or PEDOT PSS.

39. An electrode for electrochemical processes comprising; graphene platelets according to claim 33; and a binder.

40. An electrode according to claim 39 wherein the binder is selected from Nafion and PVDF.

41. A method for producing an electrode according to claim 40, comprising: creating a mixture containing graphene platelets according to claim 33 and a binder; and coating the mixture onto an electrode substrate.

42. A method for producing dispersible graphene platelets including the steps of: a. suspending graphite or graphene in a solution containing an organic nitrile, an ester and water; and, b. reacting the solution containing suspended graphite or graphene with an oxidant to at least partially functionalise edge regions of the graphite or graphene.

43. The method according to claim 42, further comprising the step of: homogenising the resultant solution obtained in step b.

44. The method according to claim 42, wherein the oxidant is ruthenium tetroxide.

45. The method according to claim 44, wherein the ruthenium tetroxide is provided via the reaction of sodium periodate with ruthenium chloride added to the solution containing suspended graphene or graphite.

46. The method according to claim 42, wherein the graphene or graphite is provided in the form of expanded graphite with an increased interlayer spacing.

47. A method for producing dispersible graphene platelets including the steps of: suspending graphite or graphene in a solution; and, contacting the solution containing suspended graphite or graphene with an oxidant to at least partially functionalise edge regions of the graphite or graphene.

Description

BRIEF DESCRIPTION OF THE FIGURES

[0045] FIG. 1 shows a schematic representation of a dispersible graphene platelet.

[0046] FIG. 2 shows a low magnification bright field TEM image of a single dispersible graphene platelet.

[0047] FIG. 3 shows a high magnification bright field TEM image of the edge of a dispersible graphene platelet.

[0048] FIG. 4 shows an SEM image of a dispersible graphene platelet at 5000× magnification.

[0049] FIG. 5A shows a Raman spectrum for a sample of graphene platelets.

[0050] FIG. 5B shows a Raman spectrum for 99.9999% graphite.

[0051] FIG. 6A shows an expanded 2D band from the Raman spectrum of the edges of a dispersible graphene platelet.

[0052] FIG. 6B shows an expanded 2D band from the Raman spectrum of the basal plane of a dispersible graphene platelet.

[0053] FIG. 7A shows the XRD spectrum for a sample of graphene platelets.

[0054] FIG. 7B shows the XRD spectrum for both 99.9999% graphite and graphene platelets.

[0055] FIG. 8 shows an XPS spectrum for a sample of graphene platelets.

[0056] FIG. 9 shows a graph of the titration of a dispersion of the graphene platelets.

DETAILED DESCRIPTION

[0057] The dispersible graphene platelet has a structure containing a base layer of graphene at a micron scale. On the surface of this base layer are irregular nanometer sized graphene layers which may be stacked as high as seven to nine layers above the base layer. Otherwise stated, the structure comprises a base layer of graphene on which at least one discontinuous layer of graphene is stacked, with each layer of graphene above the base layer having a smaller surface area than the layer it is stacked upon. The edges of the base layer and the discontinuous layers stacked upon it are all at least partially functionalised, providing a structure with graphene-like properties owing to the base layer and improved dispersibility owing to the increased amount of functionalised groups on each platelet.

[0058] FIGS. 1 and 2-4 show a schematic view and microscopy images respectively of a dispersible graphene platelet 10. The base graphene layer 1 is sized at a micron level, and features functionalised groups 5 such as hydroxyl or carboxyl acids around its edges. Platelet 10 further includes a discontinuous graphene layer 2 stacked on the surface of base layer 1. Further discontinuous graphene layers 3 and 4 are stacked on top of layer 2, the surface area of each discontinuous layer may be smaller relative to the layer below it. The edges of each discontinuous layer also feature a degree of functionalisation in the form of functionalised groups 5.

[0059] In a preferred embodiment, RuO.sub.4 may be used as the oxidant for functionalising the edges of the graphene platelets. RuO.sub.4 is suitable owing to its strong but selective oxidation effects, allowing the partial conversion of the outermost rings of the graphene structure to carboxylic acids or phenols while leaving the inner structure unmodified. RuO.sub.4 can be provided to the graphene or graphite via the reaction of RuCl.sub.3 and NaIO.sub.4 in solution.

[0060] In another preferred embodiment, the graphite used to produce the dispersible graphene platelets may be first thermally expanded to increase the interlayer spacing prior to being placed in solution. This may, in one non-limiting example, be carried out at temperatures between 700-1000° C. Graphite treated in this way is commonly referred to as expanded graphite.

[0061] The produced graphene platelet dispersion may be used to produce electrically conducting materials. For instance, it may be desirable to use these platelets to fabricate electrodes for electrochemical processes using a mixture of a dispersion of platelets with a binder such as Nafion or PVDF and coating the resultant mixture onto an electrode surface. An electrode produced in this manner could then be used in a battery or in electrochemical processes such as CO.sub.2 reduction.

[0062] In some embodiments, the produced graphene platelets can be further functionalised by binding of metal ions to either the functionalised edges or the surface of the platelet. In some preferred embodiments, the metal ions are selected from iron, copper, cobalt and tin.

[0063] The present disclosure will become better understood from the following example of a non-limiting embodiment of a method for producing the aforementioned graphene platelets.

[0064] In a first experiment, 100 mg of graphene with 99.9999% purity was suspended in a solution containing 2 mL of MeCN, 2 mL of EtOAc, and 2 mL of water. 222 mg (0.125 eq) of NaIO.sub.4 and 4 mg (0.002 eq) of RuCl.sub.3.xH.sub.2O. The resulting mixture was cooled using an ice bath and homogenized at 20000 rpm for 1 hour. Following this, the mixture was ultrasonicated for 2 hours, filtered, and washed with water and 1 M HCl until the filtrate was colourless. The filtrate was then washed with water until the filtrate was neutral. The filtrate was then freeze dried to produce a black powder containing edge functionalised graphene platelets.

[0065] In a second experiment, graphite (20 g, 1.67 mol) was suspended in MeCN (400 mL), EtOAc (400 mL) and water (600 mL). NaIO.sub.4 (71.2 g, 333 mmol) and RuCl.sub.3.xH.sub.2O (820 mg, 3.4 mmol, ˜0.2 mol %) were added and the resulting mixture was cooled in an ice bath and homogenized (˜20000 rpm) for 1 hour. The homogenizer was then removed and the mixture was ultrasonicated for 2 hours. The suspension was filtered, then the filtered solid was washed with water (100 mL) to remove excess, 1 M HCl until the filtrate was colourless, then again with water until the filtrate was neutral. The resulting solid could be suspended in water and freeze dried or washed with ethanol and dried in vacuo to yield the product as a black powder.

[0066] It will be understood that while the ruthenium tetroxide was formed in these experiments by sodium periodate and ruthenium chloride, other oxidants such as sodium hypochlorite may be used instead.

[0067] It has also been found that a longer lasting dispersion can be achieved by removing non-dispersable particles. This may be carried out by an additional process on the dried powder, comprising sonicating a dispersion of the dried powder in water for up to 30 minutes and allowing the resulting dispersion to either settle for up to 48 hours or centrifuging the dispersion. The dispersion supernatant can then be decanted to remove the settled particles, and then the supernatant filtered to obtain the graphene powder. This powder can then be washed with an organic solvent such as ethanol or acetone and dried in vacuo or freeze dried.

[0068] A number of experiments were carried out to characterize the platelets and verify the presence of functional groups at the edges of each layer. These are described below.

[0069] Raman spectroscopy was used to compare the chemical structure of the produced graphene platelets to that of bulk graphite. Referring to FIGS. 5A and 5B, the Raman spectra of produced graphene platelets and 99.9999% pure graphite are shown respectively. Both spectra show a D band 6, 6′, a G band 7, 7′, and a 2D band 8, 8′. Graphene structures produced by reduced graphene oxide which typically show D bands larger than the G band which is not the case for the produced platelets. This suggests that the platelets are substantially graphene. Referring to FIGS. 6A and 6B, analysis of the 2D Raman bands of the edge and basal planes respectively of the graphene plates allowed the determination of a thickness metric M, which can be used to determine the number of monolayers per graphene flake NG according to the equation N.sub.G=10.sup.0.84M+0.45M.sup.2. This confirmed that there were 2 layers at the graphene platelet edges and up to 6 layers on the basal plane.

[0070] Referring to FIGS. 7A and 7B, this is further backed up by the results of x-ray diffraction, where the graphene platelet spectrum 9 is substantially in line with the spectrum of graphite 11. The diminished intensity is expected as XRD provides a measure of crystallinity and graphite, consisting of numerous graphene layers necessarily has a far greater degree of crystallinity than graphene platelets which only have a few layers. The slight shift in the platelet spectrum 9 compared to graphite 11 is attributed to the functional groups at the edges increasing the interlayer distance.

[0071] The presence of the functional groups was investigated using X-ray photoelectron spectroscopy. This showed a composition of 94% C and around 6% O similar again to graphite. The XPS spectra as shown in FIG. 8 shows the presence of 3 different types of C atoms, aromatic C at 284.5 eV (14 in FIG. 8), phenolic C at 286.3 eV (13 in FIG. 8) and carboxyl C at 289.8 eV (12 in FIG. 8), suggesting the presence of carboxylic acid and phenol groups. Thermogravimetric analysis was conducted to calculate a carboxylic acid content of 0.15 mEq/g. High angle annular dark field (HAADF) scanning transmission electron microscopy showed bright edges attributed to the presence of oxygen atoms at these locations, suggesting successful edge functionalisation of the graphene platelets. The presence of both carboxyl and phenolic groups was further supported by titration of a dispersion of the edge functionalized graphene platelets in 0.1 M NaOH by 0.1 M HCl, as shown in FIG. 9 which shows two pKa values at pH=4.2 and 8.0, attributable to the carboxyl and phenolic groups, respectively.

[0072] With the structure of the platelets established, experiments were carried out to measure the dispersibility and conductivity of the platelets, as well as their ability to be fabricated into polymer composites.

[0073] The edge functionalised graphene platelets were found to allow suspensions in water at concentrations of up to 700 mg/mL in contrast to the 0.55 mg/L previously achieved by previous methods. Suspensions of up to 10 mg/L edge functionalised graphene in water were found to be stable for at least 3 months. At suspensions over 10 mg/mL, settling of the platelets was observed in solution, however redispersion could be achieved with brief shaking of the solution. Suspensions of 100 mg/mL have been found to be stable in water for at least 6 hours. Suspensions of 50 mg/mL have been found to be stable in organic solvents such as toluene, ethanol, NMP and DMF for at least 6 hours. Improved dispersion was also found in other solvents including IPA, MeOH, CH.sub.2Cl.sub.2, DMF, and THF, and suggests that the platelets may also have high dispersion in other solvents not explicitly mentioned.

[0074] For suspensions with a relatively high proportions of graphene platelets to solvent, the nature of the resultant solution may change. Suspensions of the edge functionalised graphene platelets with more than 25 wgt % edge functionalised graphene in water have been found to form a paste, while suspensions with more than 35 wgt % edge functionalised graphene in water have been found to form a moldable dough. The ability of the resultant dough to be molded allows the forming of almost any shape from the material. Pastes have been observed in 250 mg/mL in water, organic solvents, and ionic liquids. Doughs have been observed in 350-700 mg/mL in water, organic solvents, and ionic liquids.

[0075] The edge functionalised graphene platelets were formed into free-standing papers using vacuum filtration and the conductivity measured by 4 point probe conductivity measurements. The free-standing paper was found to have a highly desirable electrical conductivity of 900 S/cm.

[0076] Alternatively, the produced platelet dispersions can be used to fabricate composite materials, for example using a polymer such as alginate, chitosan, PVA, PEG, PU, PEI, PVDF or PEDOT PSS. In a first test experiment, 50 mg of platelets and 100 mg of polyvinyl alcohol (PVA) were stirred in 150 mL of water at 60° C. for between 6 and 8 hours until it was concentrated to 10-15 mL. Drop casting was then used to produce free-standing films of a PVA-graphene platelet composite. In another composite fabrication proof of concept test, a dispersion of 70% graphene platelets and 30% chitosan in water were 3D extrusion printed to form a scaffold.

[0077] The produced platelet dispersions were also used to fabricate metal functionalised graphene platelets. A proof of concept test was carried out comprising mixing a 0.1 mg/mL solution of iron chloride (FeCl.sub.3) with a 1 mg/mL graphene platelet dispersion. The mixture was then stirred for 30 minutes at room temperature before being centrifuged, washed with water to remove excess iron chloride, then freeze dried. This successfully resulted in Fe-functionalised graphene platelets as measured by XPS and SEM imagery, with XPS showing substitutional iron doping at the surface at 0.4 at. %. Fe-functionalised graphene platelets showed magnetic behavior.

[0078] Further functionalisation was achieved by annealing the Fe-functionalised platelets at 750° C. under N.sub.2 gas for 1 hour, resulting in a dispersion of iron/iron oxide nanoparticles across the platelet surface. Similar tests, using copper chloride and tin chloride in place of iron chloride resulted in copper/copper oxide and tin/tin oxide nanoparticles being bound to the platelets respectively.

[0079] In the foregoing description of certain embodiments, specific terminology has been resorted to for the sake of clarity. However, the disclosure is not intended to be limited to the specific terms so selected, and it is to be understood that each specific term includes other technical equivalents which operate in a similar manner to accomplish a similar technical purpose.

[0080] In this specification, the word “comprising” is to be understood in its “open” sense, that is, in the sense of “including”, and thus not limited to its “closed” sense, that is the sense of “consisting only of”. A corresponding meaning is to be attributed to the corresponding words “comprise”, “comprised” and “comprises” where they appear.

[0081] In addition, the foregoing describes only some embodiments of the invention(s), and alterations, modifications, additions and/or changes can be made thereto without departing from the scope and spirit of the disclosed embodiments, the embodiments being illustrative and not restrictive.

[0082] Furthermore, invention(s) have described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention(s). Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment.